Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | WZ3105 | GDSC1000 | pan-cancer | AAC | 0.011 | 0.7 |
mRNA | VU0155056 | CTRPv2 | pan-cancer | AAC | 0.014 | 0.7 |
mRNA | Sildenafil | CTRPv2 | pan-cancer | AAC | -0.014 | 0.7 |
mRNA | VX-702 | GDSC1000 | pan-cancer | AAC | -0.013 | 0.7 |
mRNA | BRD-K33514849 | CTRPv2 | pan-cancer | AAC | -0.045 | 0.7 |
mRNA | Rapamycin | gCSI | pan-cancer | AAC | 0.021 | 0.7 |
mRNA | etomoxir | CTRPv2 | pan-cancer | AAC | 0.014 | 0.7 |
mRNA | ZSTK474 | GDSC1000 | pan-cancer | AAC | 0.011 | 0.7 |
mRNA | Nilotinib | GDSC1000 | pan-cancer | AAC | -0.013 | 0.7 |
mRNA | fingolimod | CTRPv2 | pan-cancer | AAC | 0.013 | 0.7 |